TPCN2 and cancer: Inhibition, knockdown or knockout of TPC2 also results in reduced proliferation, migration, and invasion as well as reduced tumor growth, metastasis formation and VEGF-induced angiogenesis in different types of cancer, including melanoma16,19–23.